These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 883281)

  • 1. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
    Tytor IaN; Koropetskiĭ VI
    Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of isoniazid and PAS on various biochemical indices of liver function in patients with tuberculosis].
    Savula MM; Tytor IaN
    Vrach Delo; 1983 Jul; (7):16-9. PubMed ID: 6624048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Functional state of the liver and the metabolism of isoniazid and PASA in adolescents with intrathoracic tuberculosis].
    Tytor IaN
    Probl Tuberk; 1976 Jul; (7):29-32. PubMed ID: 959195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM; Kiselova ES
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
    Averbakh MM; Keleberda KIa; Gergert VIa; Mingazitinova DM
    Probl Tuberk; 1980 Mar; (3):27-30. PubMed ID: 6994091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of liver function in pulmonary tuberculosis with the aid of ueviridin test and the indicators of urinary excretion of antitubercular agents].
    Savula MM; Tytor IaM; Piatnochka IT
    Sov Med; 1976 Nov; (11):109-12. PubMed ID: 1006371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis].
    Rykowska Z
    Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemoblastic reaction in a patient with pulmonary tuberculosis developed after the use of tubazid and PAS].
    Samillo GK; Al'tshuler ML
    Vrach Delo; 1974 Sep; 0(9):77-8. PubMed ID: 4428720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of carbohydrate metabolism after administration of isoniazid, streptomycin and PAS and their correction with thiamine and nicotinic acid].
    Chirkin AA; Romanovskiĭ RV; Solov'ev IuA
    Probl Tuberk; 1986; (5):61-4. PubMed ID: 3737600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical picture of erythema fixum generalisatum caused by PAS hypersensitivity observed in 41-year-old male with pulmonary tuberculosis after a prolonged treatment with antitubercular agents (INH and PAS)].
    Laszczka C
    Gruzlica; 1965 Oct; 33(10):935-7. PubMed ID: 4222649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 15. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of chemotherapy and short-term pneumoperitoneum in the treatment of destructive pulmonary tuberculosis].
    Ursov IG; Reĭkhrud VM
    Probl Tuberk; 1976 Nov; (11):27-30. PubMed ID: 1019122
    [No Abstract]   [Full Text] [Related]  

  • 18. [Side-effects in chemotherapy of pulmonary tuberculosis].
    Savula MM; Smachilo DT; Kiselova ES
    Probl Tuberk; 1976 Feb; (21):39-43. PubMed ID: 1264981
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
    Ockerman PA; Ryde C
    Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
    Sabula MM
    Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.